Not one, but many: developing a multi-indication pricing model for medicines in Belgium

Back ground: Current pricing and reimbursement models that focus on one indication at a time are not suited to address the market access of multi-indication medicines. Therefore, the aim of this study is to co-create with Belgian stakeholders a multi-indication pricing model and procedural pathway,...

Descripción completa

Detalles Bibliográficos
Autores principales: Maes, Ingrid, Kok, Eline, De Torck, Pieter-Jan, Mestre-Ferrandiz, Jorge, Simoens, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10575738/
https://www.ncbi.nlm.nih.gov/pubmed/37841908
http://dx.doi.org/10.3389/fphar.2023.1199253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10575738/
https://www.ncbi.nlm.nih.gov/pubmed/37841908
http://dx.doi.org/10.3389/fphar.2023.1199253

Ejemplares similares